Celldex Therapeutics
CLDX • NASDAQ • Stock Fundamentals
Celldex Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Anthony S. Marucci, with a market cap of $2.4B.
Market Cap$2.4B
Employees160.0
CEOAnthony S. Marucci
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Celldex Therapeutics FAQ
Common questions about Celldex Therapeutics
Celldex Therapeutics (CLDX) has a market capitalization of $2.4B and trades on NASDAQ.
Celldex Therapeutics has approximately 160 employees.